Welcome to the latest edition of the HSA newsletter, Connections. 

Welcome to the Summer edition of the HSA newsletter. I hope all of our members have a great summer break.

In good news I have recently been notified by kitea that the phase 1 trial I mentioned in the last newsletter has been approved and will probably start in April this year. This will be a very small trial limited to people who can give informed consent in Auckland New Zealand and consist of 10 adults followed by 10 children. This trial is the first step to get the device approved in humans and only confirms that the sensor is safe for use in humans, it does not prove the efficacy of it.